Solid cancer as second malignancy in primary hematological cancer after conventional Treatment- A single institutional study

MLA

Radheshyam Naik, et al. “Solid Cancer as Second Malignancy in Primary Hematological Cancer after Conventional Treatment- A Single Institutional Study.” IP International Journal of Medical Paediatrics and Oncology, vol. 6, Apr. 2020, pp. 27–31. EBSCOhost, https://doi.org/10.18231/j.ijmpo.2020.006.

APA

Radheshyam Naik, Sulav Sapkota, & Mona Priyadarshini. (2020). Solid cancer as second malignancy in primary hematological cancer after conventional Treatment- A single institutional study. IP International Journal of Medical Paediatrics and Oncology, 6, 27–31. https://doi.org/10.18231/j.ijmpo.2020.006

Chicago

Radheshyam Naik, Sulav Sapkota, and Mona Priyadarshini. 2020. “Solid Cancer as Second Malignancy in Primary Hematological Cancer after Conventional Treatment- A Single Institutional Study.” IP International Journal of Medical Paediatrics and Oncology 6 (April): 27–31. doi:10.18231/j.ijmpo.2020.006.